83 related articles for article (PubMed ID: 20003054)
21. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
[TBL] [Abstract][Full Text] [Related]
22. CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes.
Haenssle H; Buhl T; Knudsen S; Krueger U; Rosenberger A; Reich K; Neumann C
Exp Dermatol; 2008 Mar; 17(3):177-87. PubMed ID: 18081852
[TBL] [Abstract][Full Text] [Related]
23. A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells.
Balan S; Kale VP; Limaye LS
Transfusion; 2009 Oct; 49(10):2109-21. PubMed ID: 19497054
[TBL] [Abstract][Full Text] [Related]
24. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints.
Rouas R; Uch R; Cleuter Y; Jordier F; Bagnis C; Mannoni P; Lewalle P; Martiat P; Van den Broeke A
Cancer Gene Ther; 2002 Sep; 9(9):715-24. PubMed ID: 12189521
[TBL] [Abstract][Full Text] [Related]
25. Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique.
Grauer O; Wohlleben G; Seubert S; Weishaupt A; Kämpgen E; Gold R
Histochem Cell Biol; 2002 Apr; 117(4):351-62. PubMed ID: 11976908
[TBL] [Abstract][Full Text] [Related]
26. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127
[TBL] [Abstract][Full Text] [Related]
27. Interferon-beta induces the development of type 2 dendritic cells.
Huang YM; Hussien Y; Yarilin D; Xiao BG; Liu YJ; Link H
Cytokine; 2001 Mar; 13(5):264-71. PubMed ID: 11243704
[TBL] [Abstract][Full Text] [Related]
28. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha.
Szabolcs P; Moore MA; Young JW
J Immunol; 1995 Jun; 154(11):5851-61. PubMed ID: 7538534
[TBL] [Abstract][Full Text] [Related]
29. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
[TBL] [Abstract][Full Text] [Related]
30. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
[TBL] [Abstract][Full Text] [Related]
31. Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production.
Adamson L; Palma M; Choudhury A; Eriksson I; Näsman-Glaser B; Hansson M; Hansson L; Kokhaei P; Osterborg A; Mellstedt H
Scand J Immunol; 2009 Jun; 69(6):529-36. PubMed ID: 19439014
[TBL] [Abstract][Full Text] [Related]
32. Biological characteristics of dendritic cells derived from peripheral blood of patients with epithelial ovarian cancer.
Lan CY; Liu JH; Xia JC; Zheng LM
Ai Zheng; 2009 Feb; 28(2):132-7. PubMed ID: 19550123
[TBL] [Abstract][Full Text] [Related]
33. Effect of insulin on functional status of cord blood-derived dendritic cells and on dendritic cell-induced CTL cytotoxicity against pancreatic cancer cell lines.
Liu QL; Wang YS; Wang JX
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):529-34. PubMed ID: 19822498
[TBL] [Abstract][Full Text] [Related]
34. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.
Sato K; Nagayama H; Takahashi TA
Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353
[TBL] [Abstract][Full Text] [Related]
35. Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy.
Elias M; van Zanten J; Hospers GA; Setroikromo A; de Jong MA; de Leij LF; Mulder NH
J Clin Apher; 2005 Dec; 20(4):197-207. PubMed ID: 15892082
[TBL] [Abstract][Full Text] [Related]
36. Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers.
Wong EC; Lee SM; Hines K; Lee J; Carter CS; Kopp W; Bender J; Read EJ
Cytotherapy; 2002; 4(1):65-76. PubMed ID: 11953043
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of dendritic cell generation for clinical use: recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14+ starting populations.
Meyer-Wentrup F; Burdach S
J Hematother Stem Cell Res; 2003 Jun; 12(3):289-99. PubMed ID: 12857370
[TBL] [Abstract][Full Text] [Related]
38. Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells.
Pullarkat V; Lau R; Lee SM; Bender JG; Weber JS
J Immunol Methods; 2002 Sep; 267(2):173-83. PubMed ID: 12165439
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.
Nair SK; Driscoll T; Boczkowski D; Schmittling R; Reynolds R; Johnson LA; Grant G; Fuchs H; Bigner DD; Sampson JH; Gururangan S; Mitchell DA
J Neurooncol; 2015 Oct; 125(1):65-74. PubMed ID: 26311248
[TBL] [Abstract][Full Text] [Related]
40. Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines.
Uslu U; Erdmann M; Wiesinger M; Schuler G; Schuler-Thurner B
Cytotherapy; 2019 Nov; 21(11):1166-1178. PubMed ID: 31668486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
